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Abstract
The purpose of this study was to develop a method of laparoscopic biliary bypass utilizing a PTFE-covered biliary stent. An
animal model of common bile duct obstruction was developed. Three days before the planned choledochojejunostomy, the
common duct in 10 female pigs was ligated using mini-laparoscopy instrumentation (2 mm) to create an obstruction model. A
laparoscopic choledochojejunostomy was then performed using intracorporal suturing (n=5) or stented (n=5) techniques. In
the sutured group, a side-to-side two-layer anastamosis was performed. In the stented group, a Seldinger technique was used
to deliver the stent into the abdomen through the small bowel and into the anterior wall of the common bile duct for
deployment across both the duct and bowel to create an anastomosis (under fluoroscopic guidance). After the surgery, the
animals were followed for 7 days, and then sacrificed to examine the anastomosis grossly and histologically. Statistical analysis
was used to compare the two groups. Although the difference was not statistically significant, the mean anastomosis time in
minutes was shorter for the stented group (37.8; range15–74 minutes) than in the sutured group (52.8; range 28–70 minutes).
All animals survived for 7 days after the procedure with no detectable biliary leaks or biliary obstruction at autopsy. These
gross findings were confirmed by pathologic examination of the anastomoses. Laparoscopic choledochojejunostomy using a
PTFE-covered metallic biliary stent can be performed to relieve common bile duct obstruction. In addition, the stent method
was as safe and effective as sutured laparoscopic choledochojejunostomy.
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Introduction
Because of the current inability to screen for peri-
ampullary malignancies and the biologic aggressive-
ness associated with these cancers, more than 80% of
patients with a malignant periampullary tumor present
with jaundice and are not amenable to surgical resec-
tion [1,2]. Relief of jaundice in these patients controls
the associated pruritus and significantly improves the
overall quality of life of the patients [3]. Methods used
to relieve jaundice are currently divided into operative
and nonoperative procedures. Prospective randomized
trials [4–8] for nonoperative methods, such as endo-
scopic stent placement across the malignant obstruc-
tion, are associated with a high initial success rate and
low procedural morbidity and mortality. Late compli-
cations can occur, such as stent obstruction leading to
recurrent jaundice and cholangitis. In contrast, the
perioperative morbidity and mortality rates are higher
with open choledochojejunostomy, but it provides
more durable relief of jaundice.
Minimally invasive biliary bypass has been proposed
to achieve long-lasting palliation with low morbidity
and mortality rates. However, there has been little
use of laparoscopic choledochojejunostomy because
it is a technically difficult procedure to perform. The
purpose of this study was to design and test a novel
method of laparoscopic choledochojejunostomy with
the following characteristics: low associated morbidity
and mortality, ease of performance, and potentially
durable results.
Materials and methods
Animal model of distal biliary obstruction
Ten female pigs, weighing 18–31 kg, were cared for ac-
cording to institutional and published NIH guidelines
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[9]. A survival surgical model of distal common bile
duct (CBD) obstruction was developed as follows:
after inducing general endotracheal anesthesia, intra-
abdominal pneumoperitoneum was established. A 10-
mm port was used for the scope and three 2-mm ports
were used for the mini-laparoscopic instruments. The
liver was retracted cephalad with gallbladder traction
through the right lower port to expose the CBD, which
was dissected free from surrounding structures and
ligated distally with a 2.0 silk suture. The animals were
followed clinically to determine their fitness and the
presence of jaundice.
PTFE-covered metallic biliary stent
The biliary stent used (W. L. Gore & Associates,
Flagstaff, AZ, USA) consists of an inner tubular lining
of nonporous polytetrafluoroethylene (PTFE), im-
permeable to bile, surrounded by a supporting stent
structure of helically wound nitinol wire (Figure 1a).
The deployed stent is 8 mm in diameter and 6 cm long
with drainage holes located at the proximal (hepatic)
end. Radio-opaque markers at the proximal and distal
ends allow visualization of the stent under fluoroscopy.
The delivery system is a push rod within a 75-cm long,
10 Fr sheath with a ‘Y’ connector for flushing and wire
manipulation.
Laparoscopic sutured and stented choledochojejunostomy
techniques
At 3–5 days after CBD ligation, the animals were
randomly assigned to receive one of two different
methods of laparoscopic choledochojejunostomy:
sutured (n=5) or stented (n=5). In the sutured group,
pneumoperitoneum (12 mmHg pressure) was estab-
lished with a Veress needle, three 10-mm and three
5-mm ports were placed under direct visualization.
The CBD was exposed in similar fashion to the CBD
ligation surgery with gallbladder traction. A free jejunal
loop was positioned adjacent to the common bile
duct. In the sutured group, a side-to-side 1-cm chole-
dochojejunostomy was performed with two layers of
running synthetic absorbable 4-0 suture using intra-
corporeal suturing techniques.
In the stented group, abdominal insufflation, port
placement, and retractor positioning were performed
in a similar fashion. The jejunal loop was positioned
adjacent to the CBD. The stent was delivered through
the abdomen using the Seldinger technique. Briefly, a
needle inside a 5 Fr Mixter Cholangiogram catheter
(Cook Inc., Bloomington, IN, USA) was inserted
through a 4-mm Berci introducer (Cook Inc.) via the
right lower quadrant 5-mm port, punctured through a
free small bowel loop exiting 10 cm proximally, and
then inserted into the previously dilated anterior wall
of the common bile duct (Figure 1b). The needle
was then removed; the cholangiogram catheter was
left in position and a 0.035-inch diameter Spencer
modified biliary guide wire (Cook Inc.) was inserted
under fluoroscopic guidance through the cholangio-
gram catheter and into the CBD and proximal biliary
tree (Figure 1c). Under fluoroscopic guidance, the
catheter was removed and the wire was then used to
guide placement of the stent delivery system into the
Figure 1. The PTFE-covered biliary stent is deployed via a sheath delivery system after delivery over a guidewire. Using the Seldinger
technique, a needle and guidewire are placed through the small bowel and across the anterior wall of the common bile duct (CBD).
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abdomen, through the jejunal loop and into the CBD
(Figure 2). Insertion and removal of the stent delivery
system through the jejunal loop produces a distal defect
(*0.5 cm) in the antimesenteric wall of the jejunal
loop, which is closed with a nonabsorbable 2-0 Endo-
stitch (United States Surgical Corporation, Norwalk,
CT, USA). The Endostitch is then used to place two
tacking sutures between the small bowel and the fat
surrounding the CBD to support the anastomosis. All
the anastomoses (stented and sutured) were performed
by the same surgeon (L.V.), who had experience in an
animal model of laparoscopic choledochojejunostomy,
and one assistant ( J.F. or C.C.).
Measured end points and statistical analysis
The time, measured in minutes, required for the
complete surgical procedure and the formation of the
choledochojejunostomy was recorded for each animal.
The animals were followed for 7 days postoperatively
and complications were documented for each animal.
After 7 days the animals were sacrificed and autopsied,
and their abdomens were inspected for evidence of
infection or biliary leak. The extrahepatic biliary trees
and jejunal loops used in the anastomoses were
harvested en bloc and fixed in formalin for gross and
histological pathologic analysis. Summary data are
presented as proportions or mean+standard devia-
tions. Comparisons between groups were made using a
two-tailed Student’s t-test. Statistical differences were
defined as p50.05.
Results
All 10 pigs successfully underwent distal CBD ligation
during survival surgery designed to create a jaundice
model. At 3–5 days after the procedure all animals were
suitable surgical candidates for biliary bypass and the
CBD was distended (10–20 mm diameter).
Figure 2. These intraoperative photographs demonstrate the steps for stent placement. (a) A silastic-covered needle after placement through
the small bowel and prior to puncture of the anterior wall of the common bile duct. (b) A guidewire is placed through the small bowel and into
the common bile duct. (c) The sheath is retracted and the stent is deployed across the small bowel-bile duct wall interface under fluoroscopic
guidance.
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Although not statistically significant, the average
time for construction of the anastomosis in the group
receiving a stented choledochojejunostomy was less
than in the sutured group (Table I). No ‘practice
attempts’ for the new stented choledochojejunostomy
method were used before embarking on the study, and
the resultant ‘learning curve’ translated into a longer
anastamosis time in the first animal (74 min), which
was reduced to 50 min in the second case. Stented
anastomosis time subsequently remained at approxi-
mately 25 min for the last three animals receiving the
stented choledochojejunostomy (range 15–74 min).
The anastomosis in the group receiving a sutured
choledochojejunostomy remained consistently around
50 min (range 28–70 min).
The clinical results of both methods of biliary bypass
were equally good. All the animals survived 7 days after
the procedure with resolution of jaundice and no
clinical evidence of complications. At necropsy, no leak
or evidence of intra-abdominal infection was identified
in animals from either group. Pathologic examination
of both the sutured and stented biliary anastomoses
showed no stenoses or occlusions of the anastomosis
(Figure 3) and histiologic examination of the duct
epithelium and small bowel mucosa showed that both
the stented and hand-sewn anastamoses were well
healed (Figure 4).
Discussion
For most patients with periampullary cancer treatment
is palliative and chiefly consists of the relief of biliary
obstruction [1,2]. Longitudinal studies after stenting
across malignant bile duct obstruction have demon-
strated the benefits of relieving jaundice. Specifically,
stenting not only relieves jaundice and pruritus but also
reverses associated anorexia and indigestion and
significantly improves the quality of life [3]. The
generally limited survival of these patients underscores
the importance of improving the quality of the patient’s
remaining days.
Endoscopic stent placement across the malignant
obstruction is currently the most frequent method used
to palliate jaundice in patients with periampullary
cancer. Based upon prospectively collected data, it
can be anticipated that patients will develop recurrent
jaundice or cholangitis secondary to stent obstruction
from biliary sludge about 3–4 months after placement
of a plastic stent (9.5–11.5 Fr) [8,10]. Larger diameter
(30 Fr) metallic stents provide more durable relief of
jaundice; however, tumor ingrowth continues to limit
patency to 4.8–10 months (median) [8,10,11].
The procedure described in this current study uses a
PTFE-covered stent delivered laparoscopically to form
a biliary-enteric bypass that should prevent the tumor
ingrowths and late occlusion which plague metal stents
placed across the tumor. However, this procedure does
place PTFE within the biliary system where it may
induce sludge formation and biliary re-occlusion.
Animal studies performed by the manufacturer
demonstrated that the nonporous ePTFE-FEP stents
used in the pigs in the current study are more resistant
to sludge-forming bacterial attachment than standard
expanded PTFE. These studies also showed no detri-
mental effects to the ePTFE-FEP after exposure to
bile for 3 months (W. L. Gore & Associates, unpub-
lished data, 2000). More importantly, the same type
of stent used in this study was used in human patients
in a recent prospective, nonrandomized study. In
this study, 42 patients with jaundice secondary to
Table I. Operative times for sutured and stented laparoscopic
choledochojejunostomy.
Anastomosis time (min) Total operative time (min)
Sutured 52.8 (range 28–70) 121 (range 75–180) (NS)
Stented 37.8 (range 15–74) 101 (range 62–150) (NS)
This table demonstrates the time required to perform a sutured or
stented choledochojejunostomy as well as the overall operative times
for each procedure.
Figure 3. After autopsy and tissue fixation the anastomosis was
transected in a coronal plane and representative images of the stented
(a) and sutured (b) anastomoses are shown.
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malignant obstruction underwent radiographic stent
placement across the malignant stricture with primary
stent patency rates of 90%, 76%, and 76% at 3, 6, and
12 months, respectively and recurrent obstructive
jaundice in only 15% of patients [12]. In summary, the
resistance of these stent materials to sludge-related
reocclusion and the positioning of the stent within
normal tissue as part of a biliary bypass around and not
through the malignancy should achieve palliation with
durability equal to traditional surgical bypass.
The theoretical advantage of this procedural ap-
proach for patients with periampullary malignancy and
jaundice is that it combines the benefits of minimally
invasive surgery, surgical bypass, and staging laparo-
scopy. Surgical bypass around the obstructed biliary
system with choledochojejunostomy provides the most
durable palliation with late recurrent jaundice rates of
less than 15% [13]. Many studies comparing open
biliary bypass to endoscopic palliation have shown that
nonoperative palliative procedures are associated with
lower procedure-related morbidity and mortality rates
and shorter recovery times than open procedures
[4,6,7]. Similarly, the benefits of laparoscopic versus
open procedures, including shorter hospital stay and
reduced procedure-associated morbidity, are well rec-
ognized. The specific benefits of a laparoscopic biliary
bypass for patients with jaundice due to malignant
obstruction are considerable. At laparoscopy, patients
can undergo more accurate staging of their disease than
is otherwise possible. Staging laparoscopy in patients
with presumably localized periampullary cancer iden-
tifies previously unrecognized metastasis in up to 20%
of cases, which predicts a very poor outcome and affects
the treatment options for these patients. Furthermore,
additional palliative procedures such as gastric bypass
are possible at laparoscopy and not at the time of endo-
scopy. Finally, placement of venous access devices can
be performed at the time of laparoscopy, sparing the
patient additional morbidity of hospital-based proce-
dures. In summary, a minimally invasive approach to
obstructive jaundice should achieve the quality of life
advantages identified with endoscopic biliary bypass
and offer additional staging information and ther-
apeutic options not possible through endoscopy.
The challenge is to develop a safe and durable
minimally invasive biliary bypass procedure that can be
widely employed in the clinical arena. Minimally in-
vasive techniques of biliary bypass have been proposed
to achieve durable palliation with low morbidity and
mortality rates; however, laparoscopic Roux-en-Y
choledochojejunostomy is a difficult procedure to per-
form and this has limited its use. Indeed, animal studies
have shown the feasibility of laparoscopic biliary bypass
using fibrin glue in an attempt to make this procedure
easier, but with a biliary leaks rate of 60% [14]. The
laparoscopically placed biliary stent described in this
study was designed specifically to overcome the steep
‘learning curve’ associated with laparoscopic Roux-en-
Y choledochojejunostomy. This newer procedure re-
quires basic laparoscopy skills and knowledge of the
Seldinger technique. Very little intra-corporal suturing
is required with the stented technique. The surgical
investigators in this study were able to master the
nuances of this particular procedure after performing
it in only five animals without ‘practice procedures’,
and by the time of study completion, a reliable
anastamosis could be performed in less than 25 min.
On the basis of these data we are optimistic that most
laparoscopic surgeons can perform this operative
procedure with minimal additional or special training.
It is important, however, to recognize the limitations
of this model as it applies to its future clinical appli-
cations. Although the initial results appear successful,
the follow-up time of the animals after the procedure
is too short (due to IACRAC animal safety concerns)
to make accurate comparisons as to the durability of
the stented versus hand-sewn anastomosis. We utilized
a jejunal loop to construct the anastomoses in the
model to simplify the procedure; however, we currently
employ a Roux-en-Y configuration for biliary bypass
procedures to palliate patients with obstructive jaun-
dice and anticipate using this same method for stent
choledochojejunostomy in future trials. The use of a
Roux limb has well-recognized advantages including
Figure 4. These photos represent typical histologic findings of each anastomosis after fixation and staining with hematoxylin and eosin. The
small bowel mucosa (M) and bile duct epithelium (D) are closely approximated in both the sutured and stented anastamoses.
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the ability to perform a combined bypass for malignant
gastric outlet obstruction; however, the use of a Roux
limb adds to the complexity and technical difficulty of
the procedure. Additionally, the mass effect caused by
the offending tumor in patients with a periampullary
malignancy and biliary obstruction is likely to present
technical challenges for the performance of stent
choledochojejunostomy. However, these questions
cannot be answered using this animal model and must
await clinical application of this new approach.
In conclusion, the ideal procedure for palliation of
patients with periampullary cancer and biliary obstruc-
tion must: (1) achieve adequate and durable biliary de-
compression; (2) be performed with limited morbidity;
(3) require technology that is easily learned and safely
performed. Currently there is no optimal procedure for
palliation of jaundice due to periampullary cancer, but
data from this animal study suggest that stent chole-
dochojejunostomy may meet these requirements.
Nevertheless, further controlled studies of this biliary
bypass technique are necessary before this approach
can be used in clinical practice.
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